Deutsch | English | Español | Français | Italiano | Português | Русский | العربية | 日本語 | 简体中文 | 繁體中文 | 한국의 | Türk | Polski
LOGO
全球生物医药及医药行业B2B门户网站
产品/服务 供应商 目录和文献    
搜寻
or
home Product News Catalogs Web TV News & Topics Featured Articles Trade Shows Sourcing Help My allbiomedical
产品新闻内容
allbiomedical > 产品新闻内容 > Fractional Arterial Oxygen Saturation, SpfO2, and rainbow SuperSensor
  
Share |
Fractional Arterial Oxygen Saturation, SpfO2, and rainbow SuperSensor

Masimo, Arterial Oxygen Saturation, SpfO2, rainbow, SuperSensor

Masimo (NASDAQ: MASI) announced the debut of the new fractional arterial oxygen saturation, SpfO2™, parameter through the rainbow® Universal ReSposable SuperSensor™, the first noninvasive sensor to provide simultaneous monitoring of SpHb®, SpCO®, SpMet®, SpfO2, SpOC™, Perfusion Index, PVI®, and Measure-Through Motion and Low Perfusion SpO2 and pulse rate.

Until now, pulse oximeters could only measure and display functional oxygen saturation (SpO2). So, when patients had elevated carboxyhemoglobin (from carbon monoxide poisoning) and/or elevated methemoglobin (negative reaction to more than 30 common drugs used in hospitals, like caines, nitrates, and Dapsone), the displayed functional oxygen saturation overestimated the actual oxygen saturation value.

Utilizing more than seven wavelengths of light and breakthrough signal processing, Masimo rainbow® Pulse CO-Oximeters™ can measure and display fractional arterial oxygen saturation (SpfO2). SpfO2 allows more precise arterial oxygenation assessment in patients with elevated dyshemoglobins, common throughout the hospital and pre-hospital setting, compared to functional oxygen saturation (SpO2).

SpfO2 may allow earlier interventions and more timely therapeutic decisions. For example, in a patient who is a smoker with an SpO2 of 98%, carboxyhemoglobin level of 12% and methemoglobin of 1%, if SpfO2 were available, it would be displayed at 85%. It is well accepted that clinicians would frequently make different diagnostic and therapeutic decisions at an oxygenation of 85% versus 98%.

"The new fractional arterial oxygenation measurement adds to the unprecedented noninvasive monitoring innovations Masimo has brought to clinicians, providing greater insight into the true state of their patients," said Masimo CEO and founder Joe Kiani. "SpfO2 will also be used with the noninvasive and continuous hemoglobin (SpHb) measurement, to assess the patient's true arterial oxygen content (SpOC) and should lead to better decisions about common therapies such as administering oxygen or red blood cell transfusions."

Both SpfO2 and the rainbow® SuperSensor are pending FDA 510(k) clearance.

标籤:
 
关于本公司:
Masimo is committed to improving patient outcomes and reducing cost of care by working with dedicated hospital staff to convert healthcare institutions around the world to Masimo SET pulse oximetry technology. We are accomplishing this goal through partnering with our patient monitoring companies and caregivers and creating innovative, cost-effective acquisition programs for Masimo SET products for the benefit of the patients. 
公司信息:
公司名称: Masimo International Sarl
地址: Puits Godet 10
城市: Neuchatel
省/州:
ZIP: 2000
国家: Switzerland
电话号码: +41-32-7201111
传真: +41-32-7201448
 
备注:本内容所提到的品牌,产品名称,产品编号,其版权都属于该公司所有。
 
这个公司的产品新闻
相关产品新闻
专题网页
内容
· Home
· 产品新闻
· 在线型录
· 网路TV
· 产业新闻
· 技术文件
· 国际展会
· 采购协助
· My Allbiomedical
特别编录
· 供应商名录
· 国际展会专刊
Allbiomedical.com
· 关于我们
· 营销您的产品
· 申请投放广告
· 合作伙伴征询
· 新闻发布
· 联系我们
· 使用条款
· 隐私权政策
· 入门方案
· 网站地图
B2B行業门户网站联盟
· Allitwares.com
· Allmetalworking.com
· Allbiomedical.com
· Allautowares.com
Buy Engineer Sample Kits
OEM Sourcing
语言
· Deutsch
· English
· Español
· Français
· Italiano
· Português
· Русский
· العربية
· 日本語
· 简体中文
· 繁體中文
· 한국의
· Türk
· Polski
 
   

版权2012年Allitwares公司版权所有。 www.allbiomedical.com是Allitwares公司的行业门户网站之一
www.allbiomedical.com是B2B在线网絡市集|B2B行业门户网站|生物医药行业的B2B外贸推广平台